JPRN-UMIN000010552
Completed
未知
Study on efficacy and safety of levetiracetam administration by nasogastric tube in patients with convulsive status epilepticus - Levetiracetam administration by nasogastric tube in convulsive status epilepticus
Department of Emergency and Critical Care Medicine, Wakayama Medical University0 sites20 target enrollmentApril 21, 2013
ConditionsConvulsive status epilepticus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Convulsive status epilepticus
- Sponsor
- Department of Emergency and Critical Care Medicine, Wakayama Medical University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patinets with non\-convulsive status epilepticus Patients required administration of sedative with anticonvulsive effect Systolic blood pressure \<60mmHg, \>\=220mmHg Heart rate \<40/min, \>\=150/min Respiration rate \<5/min, \>\=40/min SpO2 \<89% Unstable state of airway Acute coronary syndrome Active gastrointestinal bleeding Patients required intermittent hemodialysis or continuous renal replacement therapy Levetiracetam allergy Patients considered as inappropriate to participate in this study by attending physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome[Sicherheit und Wirksamkeit von Levetiracetam (Keppra) für die Behandlung des stationären Alkoholentzugsyndroms] - Keppra 1alcohol withdrawal syndrome (AWS) in inpatientsEUCTR2005-001486-33-DECharité Campus Mitte, Klinik für Psychiatrie und Psychotherapie120
Active, not recruiting
Not Applicable
Efficacy and safety of Levetiracetam treatment in patients suffering from Restless Legs SyndromeEficacia y seguridad de un tratamiento con levetiracetam en pacientes con síndrome idiopático de piernas inquietasRestless legs syndrome (RLS)EUCTR2005-001516-41-ESClínica Plató Fundació Privada12
Recruiting
Phase 2
The effect of levetiracetam and phenobarbital on the control of neonatal seizuresIRCT20160523028008N23Hamedan University of Medical Sciences40
Completed
Phase 2
evetiractem for the prophylactic treatment of pediatric migrainemigraine headache.migraine without aura or clasic migraineIRCT2017021632603N1Vice chancellor for research, Tehran university of medical sciense68
Not yet recruiting
Not Applicable
Phenobarbitone vs Levetiracetam in term asphyxiated babies.CTRI/2020/05/025416Department of Neonatology